Our top pick for
AVITA Medical Inc is a medical devices business based in the US. AVITA Medical shares (RCEL) are listed on the NASDAQ and all prices are listed in US Dollars. AVITA Medical employs 108 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$17.32|
|52-week range||$16.52 - $28.49|
|50-day moving average||$18.39|
|200-day moving average||$19.13|
|Wall St. target price||$40.60|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.23|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||-0.29%|
|1 month (2021-09-23)||-5.82%|
|3 months (2021-07-23)||-10.12%|
|6 months (2021-04-23)||-15.01%|
|1 year (2020-10-23)||-26.52%|
|2 years (2019-10-23)||80.98%|
|3 years (2018-10-23)||1,178.23%|
|5 years (2016-10-21)||882.58%|
|Revenue TTM||$29.2 million|
|Gross profit TTM||$23.3 million|
|Return on assets TTM||-15.95%|
|Return on equity TTM||-28.27%|
|Market capitalisation||$432.4 million|
TTM: trailing 12 months
There are currently 1.2 million AVITA Medical shares held short by investors – that's known as AVITA Medical's "short interest". This figure is 6.7% down from 1.3 million last month.
There are a few different ways that this level of interest in shorting AVITA Medical shares can be evaluated.
AVITA Medical's "short interest ratio" (SIR) is the quantity of AVITA Medical shares currently shorted divided by the average quantity of AVITA Medical shares traded daily (recently around 96432.996108949). AVITA Medical's SIR currently stands at 12.85. In other words for every 100,000 AVITA Medical shares traded daily on the market, roughly 12850 shares are currently held short.
However AVITA Medical's short interest can also be evaluated against the total number of AVITA Medical shares, or, against the total number of tradable AVITA Medical shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AVITA Medical's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 AVITA Medical shares in existence, roughly 50 shares are currently held short) or 0.0101% of the tradable shares (for every 100,000 tradable AVITA Medical shares, roughly 10 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against AVITA Medical.
Find out more about how you can short AVITA Medical stock.
We're not expecting AVITA Medical to pay a dividend over the next 12 months.
AVITA Medical's shares were split on a 1:5 basis on 29 June 2020. So if you had owned 5 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your AVITA Medical shares – just the quantity. However, indirectly, the new 400% higher share price could have impacted the market appetite for AVITA Medical shares which in turn could have impacted AVITA Medical's share price.
Over the last 12 months, AVITA Medical's shares have ranged in value from as little as $16.52 up to $28.49. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AVITA Medical's is 0.2921. This would suggest that AVITA Medical's shares are less volatile than average (for this exchange).
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.